Royal Bank of Canada »

Indivior Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $929k 30k 30.63

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Vanguard Capital Management
State Street Corporation
Two Seas Capital
Millennium Management
Hanna Zanoni
Madison Avenue Partners
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Mangrove Partners
Goldman Sachs Group

View all funds holding Indivior Pharmaceuticals